#USA #Minneapolis #FLEX Vessel Prep #VentureMed #Flex Vascular

VentureMed Group Transitions to Flex Vascular

On March 5, 2026, the innovative medical device company VentureMed Group, Inc. announced that it will now operate under the name Flex Vascular. This rebranding reflects the company's dedication to advancing vascular technologies, particularly in vessel preparation and access management for arteriovenous (AV) fistulas and peripheral vascular diseases. The shift to Flex Vascular aligns closely with the company's flagship technology, the FLEX Vessel Prep™ System, which exemplifies their commitment to innovation in the vascular field.

A Name that Represents Innovation

Denis Harrington, the Chief Executive Officer of the company, emphasized that the name Flex Vascular more accurately illustrates their core mission and the advanced technologies they offer to healthcare professionals and patients alike. The change in branding came at a time when the adoption of the FLEX Vessel Prep™ System was increasingly recognized, making it essential for the company’s public identity to resonate with their specialty in vascular health.

No Changes in Core Operations

Despite the new name, it is essential to note that VentureMed Group, Inc. will remain the official legal entity. The rebranding as Flex Vascular does not entail any alterations in ownership, corporate leadership, or product offerings. The focus remains on maintaining the same high standards for customer service and product quality that their clients have come to expect. Existing contracts and pricing will remain unaffected, ensuring a seamless transition for all stakeholders involved.

The FLEX Vessel Prep™ System

Central to their product lineup is the FLEX Vessel Prep™ System, which is designed to enhance vessel preparation using proprietary Kinetic Endovascular Micro-incision Creation (KEMIC) technology. This advanced system sets itself apart from traditional methods by utilizing controlled motion, which facilitates the creation of precise micro-incisions in vascular structures. Such innovation not only leads to improved luminal gain but also enhances drug uptake potential when used in combination therapies. Ultimately, the KEMIC technology is designed to minimize vessel trauma, which is paramount in lowering the risk of restenosis, thus improving overall patient outcomes.

What Lies Ahead for Flex Vascular

As Flex Vascular, the company aims to strengthen its presence in the vascular market, promising continued innovation that aligns with today’s healthcare needs. Over time, customers and partners can expect to see the new name featured across various communication channels, including digital platforms and marketing materials. This strategic branding update is poised to better connect with clinicians and patients, signaling a clear direction for future advancements in vascular care.

In conclusion, the transition to the name Flex Vascular marks a significant step in the company’s journey, establishing a brand that embodies its innovative approach to vascular technology. For more insights on their products and updates, individuals are encouraged to visit Flex Vascular's official website.